The right time for American Society of Clinical Oncology (ASCO) and Cancer Care Ontario (CCO) on metastatic castration-resistant prostate cancer.
A recent study published in the Journal of Clinical Oncology links male pattern baldness with elevated risk of aggressive prostate cancer.
ALCHEMIST to screen 8,000 patients with early-stage lung cancer, randomly assigning patients with EGFR mutations or rearrangement of the ALK gene.
Newly released 2014 Cancer Progress Report from the American Association for Cancer Research highlights the need for increased federal funding of cancer research.
1 in 10 patients with cancer would be more accurately diagnosed if their tumors were defined by cellular and molecular criteria.
A retrospective study identifies a potential link between NSAID use and breast cancer recurrence and overweight and obese women.
More research is warranted to determine the effectiveness of Botox® (onabotulinumtoxinA) injections in slowing the growth of tumors.
The new test is more sensitive than fecal occult blood tests but carries a higher risk of false-positives.
Early studies show that continual low-dose chemotherapy lessens toxicity.
After positive results, there is debate regarding the roll out of pasireotide for patients with pancreatic cancer undergoing surgery.
A review of data suggests that HPV testing alone every 3 years provides a high level of reassurance against cervical cancer.
While guidelines recommend against routine use, further investigation and data collection on this topic is warranted.
A review demonstrated an improvement with proton beam therapy compared with those who received photon intensity-modulated radiation therapy.
Use of statins in patients with colorectal cancer associated with reduced colorectal cancer-specific mortality.
Changes in adipose tissue precede the development of cachexia symptoms, and suggest a treatment approach.
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|